Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Confluent (CFLT) EBT: 2020-2025

Historic EBT for Confluent (CFLT) over the last 6 years, with Sep 2025 value amounting to -$65.0 million.

  • Confluent's EBT rose 8.74% to -$65.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$330.4 million, marking a year-over-year increase of 0.69%. This contributed to the annual value of -$357.6 million for FY2024, which is 16.53% up from last year.
  • Latest data reveals that Confluent reported EBT of -$65.0 million as of Q3 2025, which was up 13.78% from -$75.3 million recorded in Q2 2025.
  • Confluent's EBT's 5-year high stood at -$44.6 million during Q1 2021, with a 5-year trough of -$150.9 million in Q1 2023.
  • In the last 3 years, Confluent's EBT had a median value of -$86.5 million in 2024 and averaged -$91.5 million.
  • As far as peak fluctuations go, Confluent's EBT plummeted by 287.15% in 2021, and later skyrocketed by 40.03% in 2024.
  • Confluent's EBT (Quarterly) stood at -$121.9 million in 2021, then increased by 2.14% to -$119.3 million in 2022, then increased by 29.12% to -$84.6 million in 2023, then decreased by 29.34% to -$109.4 million in 2024, then climbed by 8.74% to -$65.0 million in 2025.
  • Its EBT stands at -$65.0 million for Q3 2025, versus -$75.3 million for Q2 2025 and -$80.8 million for Q1 2025.